ES2377194T3 - Suplemento de medios de cultivo de gametos y de embriones de mamíferos y procedimiento de utilización del mismo - Google Patents

Suplemento de medios de cultivo de gametos y de embriones de mamíferos y procedimiento de utilización del mismo Download PDF

Info

Publication number
ES2377194T3
ES2377194T3 ES01946230T ES01946230T ES2377194T3 ES 2377194 T3 ES2377194 T3 ES 2377194T3 ES 01946230 T ES01946230 T ES 01946230T ES 01946230 T ES01946230 T ES 01946230T ES 2377194 T3 ES2377194 T3 ES 2377194T3
Authority
ES
Spain
Prior art keywords
preparation
supplement
medium
approximately
recombinant human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01946230T
Other languages
English (en)
Spanish (es)
Inventor
David K. Gardner
Michelle T. Lane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitrolife AB
Vitrolife Sweden AB
Original Assignee
Vitrolife AB
Vitrolife Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26905361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2377194(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitrolife AB, Vitrolife Sweden AB filed Critical Vitrolife AB
Application granted granted Critical
Publication of ES2377194T3 publication Critical patent/ES2377194T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/905—Hyaluronic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES01946230T 2000-06-09 2001-06-09 Suplemento de medios de cultivo de gametos y de embriones de mamíferos y procedimiento de utilización del mismo Expired - Lifetime ES2377194T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21064900P 2000-06-09 2000-06-09
US210649P 2000-06-09
US21223200P 2000-06-16 2000-06-16
US212232P 2000-06-16
PCT/US2001/018766 WO2001094552A2 (fr) 2000-06-09 2001-06-09 Supplement de milieu de culture d'embryons et de gametes de mammiferes, et methode d'utilisation correspondante

Publications (1)

Publication Number Publication Date
ES2377194T3 true ES2377194T3 (es) 2012-03-23

Family

ID=26905361

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01946230T Expired - Lifetime ES2377194T3 (es) 2000-06-09 2001-06-09 Suplemento de medios de cultivo de gametos y de embriones de mamíferos y procedimiento de utilización del mismo

Country Status (14)

Country Link
US (2) US6762053B2 (fr)
EP (2) EP1287119B1 (fr)
JP (1) JP4202121B2 (fr)
KR (1) KR100736422B1 (fr)
CN (1) CN1250712C (fr)
AT (1) ATE532855T1 (fr)
AU (2) AU6830801A (fr)
BR (1) BR0111537A (fr)
CA (1) CA2410931C (fr)
DK (1) DK1287119T3 (fr)
ES (1) ES2377194T3 (fr)
HK (1) HK1059454A1 (fr)
NZ (1) NZ523481A (fr)
WO (1) WO2001094552A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR803501A0 (en) * 2001-10-02 2001-10-25 Xeno Trans Ltd Gene transfer composition and method
CA2417689C (fr) * 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Methodes ameliorees de culture in vitro de cellules de mammiferes
AU2003232183B2 (en) * 2002-06-17 2008-08-14 Region Hovedstaden V/Herlev Hospital In vitro fertilisation
JP2004238392A (ja) * 2003-01-14 2004-08-26 Nipro Corp 安定化された蛋白質性製剤
PL1697504T3 (pl) 2003-11-26 2012-01-31 Merck Serono Sa Zastosowanie cytokin typu IL-6 do dojrzewania oocytów
CA2547787A1 (fr) * 2003-12-01 2005-06-16 Vertex Pharmaceuticals Incorporated Compositions renfermant des cellules hepatiques foetales, et procedes utiles pour le traitement de l'infection par le vhc
US7989205B2 (en) * 2005-10-06 2011-08-02 American Cryostem Corporation Cell culture media, kits and methods of use
NO331476B1 (no) * 2007-12-21 2012-01-16 Jaffar Ali Bin M Abdullah Proteinfri gamete- og embryo-handtering samt dyrkningsmedieprodukter inneholdende metylcellulose
US20090305415A1 (en) * 2008-06-05 2009-12-10 Huang Lynn L H Method for preserving proliferation and differentiation potential of undifferentiated cells
US9688956B2 (en) 2008-06-05 2017-06-27 National Cheng Kung University Method for preserving proliferation and differentiation potential of mesenchymal stem cells
US10894944B2 (en) * 2009-04-10 2021-01-19 Monash University Cell culture media
CN102812121A (zh) * 2010-01-25 2012-12-05 文特里亚生物科学公司 用于改善蛋白质生产的方法和组合物
UA117448C2 (uk) * 2011-06-29 2018-08-10 Зе Дженерел Хоспітел Корпорейшн Середовище клітинної культури для культивування ооцита
EP2941482B1 (fr) * 2013-01-04 2020-11-25 Board Of Regents, The University Of Texas System Compositions comprenant du citrate et leurs applications
NZ740967A (en) * 2015-10-23 2024-03-22 Isifer Ab Composition for treatment of infertility in a female subject
CN107365739B (zh) * 2017-08-17 2021-03-30 四川农业大学 一种哺乳动物胚胎细胞的培养方法
WO2020210741A1 (fr) * 2019-04-12 2020-10-15 FUJIFILM Irvine Scientific, Inc. Supplément de milieu de culture embryonnaire
WO2024018452A1 (fr) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Variants de protéine d'albumine, leur production et leurs utilisations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327177A (en) * 1969-04-10 1982-04-27 Wallace Shrimpton Method and means for controlling the sex of mammalian offspring and product therefor
US4007087A (en) * 1975-10-17 1977-02-08 Gametrics Limited Sperm fractionation and storage
SE449003B (sv) * 1985-10-18 1987-03-30 Pharmacia Ab Sett att in vitro avskilja spermier med egen rorelseformaga medelst penetrationsmedium i vilket ingar hyaluronsyrasalt
US6048728A (en) * 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
US5102783A (en) * 1990-01-12 1992-04-07 Vetrepharm, Inc. Composition and method for culturing and freezing cells and tissues
US5096822A (en) * 1990-07-26 1992-03-17 W. R. Grace & Co.- Conn. Bovine embryo medium
FR2686620B1 (fr) * 1992-01-27 1995-06-23 Rhone Poulenc Rorer Sa Serum-albumine humaine, preparation et utilisation.
JPH06227974A (ja) * 1993-01-29 1994-08-16 Kyowa Hakko Kogyo Co Ltd 栄養組成物
US5496720A (en) * 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
JP3660026B2 (ja) * 1995-09-04 2005-06-15 扶桑薬品工業株式会社 体外受精用培地組成物
CA2235069C (fr) * 1995-10-19 2010-12-14 Advanced Reproduction Technologies, Inc. Procedes et compositions permettant d'ameliorer la survie et les fonctions de cellules germinales et d'embryons
US6043092A (en) * 1996-03-18 2000-03-28 University Of Pittsburgh Cell culture media for mammalian cells
EP0947581A4 (fr) 1996-08-08 2004-07-28 Mitsubishi Pharma Corp Milieu de culture et ses applications
US6010448A (en) * 1997-10-17 2000-01-04 Medworks Corp Embryo transfer arrangement
US6153582A (en) * 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
CA2349823C (fr) 1998-11-30 2005-11-01 Ivf Sciences Colorado, Inc. Systeme et milieux de culture sequentiels utilises dans la fecondation in vitro

Also Published As

Publication number Publication date
CN1446256A (zh) 2003-10-01
NZ523481A (en) 2004-08-27
KR20030032960A (ko) 2003-04-26
HK1059454A1 (en) 2004-07-02
US20040214320A1 (en) 2004-10-28
JP2003535585A (ja) 2003-12-02
US6762053B2 (en) 2004-07-13
WO2001094552A3 (fr) 2002-08-01
DK1287119T3 (da) 2011-12-12
EP1287119B1 (fr) 2011-11-09
WO2001094552A2 (fr) 2001-12-13
AU6830801A (en) 2001-12-17
KR100736422B1 (ko) 2007-07-09
CN1250712C (zh) 2006-04-12
AU2001268308B2 (en) 2006-01-12
ATE532855T1 (de) 2011-11-15
BR0111537A (pt) 2003-07-01
CA2410931C (fr) 2010-04-06
EP1287119A2 (fr) 2003-03-05
CA2410931A1 (fr) 2001-12-13
US20020042132A1 (en) 2002-04-11
EP2228439A1 (fr) 2010-09-15
JP4202121B2 (ja) 2008-12-24

Similar Documents

Publication Publication Date Title
ES2377194T3 (es) Suplemento de medios de cultivo de gametos y de embriones de mamíferos y procedimiento de utilización del mismo
Stojkovic et al. Effects of high concentrations of hyaluronan in culture medium on development and survival rates of fresh and frozen-thawed bovine embryos produced in vitro
KR20190090780A (ko) 세포 생존능력을 유지시키기 위한 조성물 및 방법
US20080200548A1 (en) N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with Infertility
JP6353615B1 (ja) 哺乳動物細胞凍結保存液
CN104350145A (zh) 用于无饲养细胞培养牛和猪的精原干细胞的方法
CN114557337B (zh) 脐带间充质干细胞无蛋白非程序冻存液及其制备方法
AU2001268308A1 (en) Mammalian gamete and embryo culture media supplement and method of using same
CN110312789A (zh) 用于卵母细胞体外成熟的组合物和方法
KR102391629B1 (ko) 펙틴과 알라닌을 이용한 세포 동결 보존용 조성물 및 이를 이용한 세포 동결 보존 방법
Palasz et al. The effect of macromolecular supplementation on the surface tension of TCM-199 and the utilization of growth factors by bovine oocytes and embryos in culture
WO2018215684A1 (fr) Moyens de culture avec des lysats plaquettaires
KR101358973B1 (ko) 트리할로오스를 이용한 정원줄기세포의 동결보존 방법
CN107787960B (zh) 视网膜色素上皮细胞的冻存液及其应用
CN108378019B (zh) 一种人精原干细胞的冻存液
KR20140046690A (ko) 트레할로오스를 포함하는 동결보존액을 이용한 돼지 정원줄기세포의 동결보존 방법
Goltsev et al. THE FUNCTIONAL ACTIVITY OF CRYOPRESEKVED HEMOPOIETIC CELLS (CPUs) DEPENDING ON THE MYELOGRAFT COMPONENT COMPOSITION